NEW DELHI: India is likely to approve the Oxford / AstraZeneca coronavirus vaccine for emergency use next week after its local manufacturer submitted additional data requested by authorities, two sources with knowledge of the matter told Reuters on Tuesday. This could be the first country to give a regulatory green …
Read More »Government Must Protect Vaccine Manufacturers Against Lawsuits, Frivolous Claims Invite Skepticism: Adar Poonawalla
Vaccine manufacturers must have protection against all lawsuits for their vaccines, especially during a pandemic, said Serum Institute of India (SII) executive director Adar Poonawalla. He also said that vaccine manufacturers are going to propose this to the government, while speaking on a virtual panel about the challenges of developing …
Read More »Government Must Protect Vaccine Manufacturers Against Lawsuits: Adar Poonawalla From IBS
Manufacturers of vaccines against coronavirus disease (Covid-19) should be protected from liability in the event of serious adverse reactions or other claims to their vaccines during a pandemic, said the executive director of the Serum Institute of India (SII). ), Adar Poonawalla. Poonawalla, who made the remarks during a virtual …
Read More »Vaccination against Covid-19 will be voluntary: Ministry of Health | India News
NEW DELHI: Getting vaccinated against Covid-19 will be voluntary, the Union’s health ministry said, while underlining that the vaccine introduced in India will be as effective as any vaccine developed by other countries. The ministry further stated that it was advisable to receive a full coronavirus vaccine schedule regardless of …
Read More »Have 1 adverse event management center in each block for vaccination campaign: Center | India News
The Center expects a “good decision” on the Covid-19 vaccine soon and has asked states to identify at least one adverse event management center in each block to monitor the safety and efficacy aspects of the jabs. “When we undertake a universal immunization program, we see some adverse effects in …
Read More »Coronavirus Highlights, Dec 14: Center Issues Vaccination Campaign Guidelines; Russian vaccine 91.4% effective
By: Express Web Desk | New Delhi | Updated: December 14, 2020 9:21:07 pm More than 75 percent of new cases are seen in 10 states and union territories. (Representative) India reported just 27,000 new cases on Monday, even as the Center issued guidelines for the Covid-19 vaccination campaign, which …
Read More »Coronavirus Highlights, Dec 13: BJP Chief Nadda Tests Positive; Bahrain approves Sinopharm vaccine
By: Express Web Desk | New Delhi | Updated: December 13, 2020 9:22:25 pm Bahrain said Sunday that it approved the use of a Chinese coronavirus vaccine, following its earlier approval of a vaccine made by Pfizer and its German partner BioNTech. (AP / File) BJP National Chairman JP Nadda …
Read More »Court Issues Notice to Serum Institute of India on Lawsuit Against Use of Name ‘COVISHIELD’ for Proposed Vaccine
A Maharashtra civil court has issued a notice to the Serum Institute of India (SII) in a bogus lawsuit that seeks to prevent the pharmaceutical company from using the trademark “COVISHIELD” or “COVID-SHIELD” or any other identical or similar name for its proposed vaccine for the Coronavirus-induced pandemic. The civil …
Read More »India Prepares for 60 Crore Covid-19 Vaccine Injections in 6-8 Months; use standard cold storage: government expert
India will deploy its vast electoral machinery to administer 600 million doses of COVID-19 vaccinates the most vulnerable people in the next six to eight months through conventional cold chain systems, the expert leading the initiative said on Friday. The government has lined up cold storage facilities with temperatures between …
Read More »Serum Institute will produce 10 crore doses every month starting next year
The Serum Institute of India plans to make up to 10 crore doses of coronavirus vaccine each month, starting next year, said CEO Adar Poonawalla. The Pune-based drug maker has partnered with global pharmaceutical giant AstraZeneca to produce the COVID-19 vaccine for the University of Oxford for low- and middle-income …
Read More »